Latest Reported Offering
$50,000
Target Amount
$5,000,000
Maximum Amount
2023-12-14
Deadline
Security Details
Type: Common Stock
Price per share: $2.00
Shares offered: 25,000+
Offering Costs
Cash commission: 3%
of the amount raised in the Offering
Equity compensation: —
A cash expense of $16,500 for set-up fees and $2,000 per month maintenance fees payable to DealMaker Securities, as well as 1% of the total Securities sold in the offering
Filing history
Form C family — 1 filing| Filed | Form | File number | Portal | What it states | What the filer said |
|---|---|---|---|---|---|
| 2022-12-21 | C | 020-31520 | DealMaker Securities LLC | $50K target, up to $5M · Common Stock at $2.00 · closes 2023-12-14 | — |
The reported figures behind Novatek Pharmaceuticals, Inc.
Form C prints a most-recent and a prior fiscal year side by side but never names them. The dashboard chains every filing into those years and plots them. EDGAR still has each Form C-AR; the dashboard lays every year they filed next to it.
- Reported financials chained into fiscal years — revenue, income, assets, cash — not one filing at a time
- A sparkline on each figure so the shape is visible before the numbers
- A revenue series dated to the filings that reported it
- The campaign as filed: target, ceiling, deadline, and the portal that ran it
- Follow it, and see it change on your watchlist
Company Information
Legal Status
Corporation
Jurisdiction
DE
Date of Incorporation
2020-04-30
Latest Metrics
Employees5
Total Assets$16,640
Cash on Hand$16,640
Revenues$0.00
Net Income$3,446,214
Crowdfunding Portals
The intermediary named in this company’s Form C filings. Investments in a Regulation Crowdfunding offering can only be made through them.